MedTrace Logo

A Bioequivalence Study of L04TD1 Compared to Administration of L04RD1 in Healthy Volunteers

NCT05568121 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2023-01-12

No results posted yet for this study

Summary

This is a randomized, open, single-dose, crossover-design, phase 1, single-center study to evaluate bioequivalence after administration of L04RD1 or administration of L04TD1 in healthy volunteers.

Conditions

  • Healthy

Interventions

DRUG

L04RD1

1 tablet of L04RD1

DRUG

L04TD1

1 tablet of L04TD1

DRUG

L04TD1

1 tablet of L04TD1

DRUG

L04RD1

1 tablet of L04RD1

Sponsors & Collaborators

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Max Age
64 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-01
Primary Completion
2022-10-09
Completion
2022-10-27

Countries

  • South Korea

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05568121 on ClinicalTrials.gov